Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Most Asian currencies weakened on Thursday as the U.S. dollar gained ground ahead of European and U.K. central bank meetings. Market jitters from a broader sell-off in global financial markets and a focus on upcoming policy decisions kept risk-sensitive currencies under pressure. The yen was notably soft ahead of Japan’s lower house elections, whil…
Todd Watanabe, President and CEO of Arcutis Biotherapeutics (NASDAQ: ARQT), sold 19,833 shares on February 2, 2026, for $505,709 to satisfy tax withholding tied to restricted stock units. The transaction leaves Watanabe with 721,306 directly held shares and several additional holdings held indirectly through trusts and an LLC. The company has poste…
Rio Tinto is widely expected to request an extension to the UK takeover timetable before the February 5 deadline, sources say, allowing more time to scrutinise early-stage merger discussions with Glencore. Some investors, particularly in Australia, are signalling opposition to any deal that involves a premium or fails to clearly create value, citin…
Toyota Motor is forecast to record a third straight quarterly drop in operating profit for the October-December period, with analysts pointing to rising costs and U.S. tariffs as key headwinds even as global vehicle sales hit a record and hybrid models remain in strong demand. The company’s full-year outlook remains elevated, supported by currency …
UroGen Pharma Ltd's Chief Medical Officer, Mark Schoenberg, sold 7,373 ordinary shares on February 3, 2026, at $19.69 apiece to satisfy withholding tax tied to settled restricted stock units. The company recently reported third-quarter 2025 results that missed consensus on earnings per share and revenue, and no analyst actions or M&A updates have b…
Adaptive Biotechnologies Chief Executive and Chairman Chad M. Robins sold 124,998 shares on February 2, 2026, for about $2.3 million under a Rule 10b5-1 plan. The transaction coincides with a year of notable revenue gains for the company and strategic agreements with Pfizer, though valuation metrics and negative EBITDA highlight ongoing financial c…
Pan American Silver (PAAS) trades like a company priced for perfection while the underlying metals cycle still has room to run. Fundamentals show healthy liquidity and low leverage, but negative free cash flow and elevated valuation metrics require discipline. This trade targets a measured long on a pullback in the mid term (45 trading days) with a…
Director Peter A. Thompson reported the sale of Sionna Therapeutics stock across two days in early February 2026, totaling $1.37 million. The transactions occurred at prices between $44.57 and $44.58 per share. The company has recently drawn contrasting analyst views: Raymond James has raised its price target and kept a Strong Buy, while RBC Capita…
Adaptive Biotechnologies Chief Scientific Officer Harlan S. Robins sold 42,788 shares across February 2 and 3, 2026, realizing approximately $799,104. The transactions were carried out under a Rule 10b5-1 plan and occurred as the company reported significant 2025 revenue gains and announced strategic collaborations and financing activity.
OpenAI is enlarging its technical consulting unit with plans to hire hundreds of staff to help large companies build bespoke AI applications and task-automation agents. The move supports a new enterprise product intended to centralize corporate AI deployments and comes as the company readies a late-2026 initial public offering and increases capital…
Alphabet told investors that its recent AI investments are producing measurable returns across both consumer and enterprise businesses, citing strong engagement with the Gemini 3 model, rapid growth in cloud revenue and a materially higher capex outlook tied to AI computing capacity. The messaging, delivered after the company’s earnings release, sh…
Chief Financial Officer Daniella Beckman sold 10,317 shares of Tango Therapeutics (NASDAQ: TNGX) on February 3, 2026, realizing roughly $126,530. The disposals, reported on a Form 4 with the Securities and Exchange Commission, were executed in two transactions and were disclosed as tax-withholding sales tied to restricted stock unit vesting. The co…
SoftBank Group shares plunged on Thursday after Arm Holdings reported weaker-than-expected licensing revenue for the December quarter. The decline in Arm, coupled with a broader technology sector pullback driven by uncertainty over artificial intelligence, pushed SoftBank down as much as 7% and helped drag the Nikkei 225 lower by 1%.
Christopher S. Ziluca, chief credit officer at Hancock Whitney Corp (HWC), sold 5,227 shares on January 23, 2026, for $68.57 per share, totaling $358,415. After the sale and a domestic-relations transfer, Ziluca directly holds 33,301.4529 shares. The transaction comes amid Hancock Whitney’s fourth-quarter 2025 results that showed a slight earnings-…
Thailand's headline consumer price index declined 0.66% year-on-year in January, marking the 10th straight month of negative annual inflation. The drop outpaced a Reuters poll forecast of a 0.40% decline and remained well under the central bank's 1-3% target. Officials expect headline inflation to stay negative through early spring, while core infl…
Jeffrey P. Klenk, Executive Vice President of Travelers Companies (TRV), sold 16,712 shares on January 23, 2026, for roughly $4.6 million at an average price of $279.7746. On the same day he exercised options to acquire 16,712 shares in two tranches, with exercise prices of $140.85 and $132.58, totaling $2,256,299. The company recently reported ope…
Asian stock markets slid on Thursday after a wave of volatility in global technology shares. Investors pared back positions following a sell-off in U.S. tech stocks, and concern that rapid advances in artificial intelligence could disrupt business models weighed on sentiment. Major indexes from South Korea to Hong Kong retreated from recent record …
MapLight Therapeutics director Robert C. Malenka sold 7,040 shares of the company's Voting Common Stock on February 2-3, 2026, at prices between $18.00 and $18.02 per share, producing proceeds of $126,860. After the transactions, Malenka directly holds 358,233 shares and indirectly holds 31,672 shares via a living trust. The company has reported fa…
Lemonade CEO Daniel A. Schreiber sold 9,108 shares on January 23, 2026, for roughly $902,056 under a pre-arranged Rule 10b5-1 plan. The stock traded at $99.04 at the time - close to its 52-week high - and has since retreated to $74.18. The company faces several near-term events, including an earnings release and the scheduled expiration of warrants…
Sony reported a 22% increase in third-quarter operating profit for October-December, with operating profit of 515 billion yen beating the LSEG analyst average of 469 billion yen. The company raised its full-year operating profit forecast by 8% to 1.54 trillion yen, citing the music business. Market concerns persist about future growth drivers for t…
Silver prices fell sharply in volatile trade, wiping out a rebound earlier in the week. Spot silver dropped about 14.7% to $75.18 an ounce while March futures slid more than 11.5% to $74.68/oz, as renewed selling coincided with a firmer dollar and traders waiting on central bank cues and U.S. payrolls data.
A global shortage of memory chips and rising memory prices are constraining smartphone shipments and denting demand for major chip industry players. Qualcomm reported weaker-than-expected orders and warned of lower revenue for the current quarter as customers struggle to secure memory to complete device builds. Arm warned its royalty revenue could …
The New York City Health Department announced it has joined the World Health Organization’s Global Outbreak Alert and Response Network (GOARN) after the United States formally withdrew from the WHO. The move aligns the city with other Democratic-led jurisdictions that have sought to retain direct channeling of international outbreak response resour…
Esther Rajavelu, who serves as Chief Executive Officer, Chief Financial Officer and Chief Business Officer at Spero Therapeutics (NASDAQ: SPRO), sold 18,442 shares on February 2, 2026 to satisfy tax withholding tied to vested restricted stock units, while also receiving a grant of restricted stock units and stock options the same day. The company r…
Natera President and CEO Steven Leonard Chapman sold 89,324 shares of common stock across February 2 and 3, 2026, generating roughly $20.7 million in proceeds at prices between $229.0846 and $234.00 per share. The transactions, disclosed on a Form 4 filing, were executed under a Rule 10b5-1 plan adopted in December 2023 and amended in December 2024…
